[1] DiNubile, M.J. and Lipsky, B.A. (2004) Complicated Infections of Skin and Skin Structures: When the Infection Is More than Skin Deep. Journal of Antimicrobial Chemotherapy, 53, ii37-ii50.
http://dx.doi.org/10.1093/jac/dkh202
[2] Shahcheraghi, F., Nasiri, S. and Noveiri, H. (2009) Detection of Extended-Spectrum ?2-Lactamases (ESBLs). Archives of Clinical Infectious Diseases, 4, 65-70.
[3] Chaudhary, U. and Aggarwal, R. (2004) Extended Spectrum Beta Lactamases (ESBL)—An Emerging Threat to Clinical Therapeutics. Indian Journal of Medical Microbiology, 22, 75-80.
[4] Paterson, D.L. and Bonomo, R.A. (2005) Extended-Spectrum Beta-Lactamases: A Clinical Update. Clinical Microbiology Reviews, 18, 657-686. http://dx.doi.org/10.1128/CMR.18.4.657-686.2005
[5] Perez, F., Endimiani, A., Hujer, K.M. and Bonomo, R.A. (2007) The Continuing Challenge of ESBLs. Current Opinion in Pharmacology, 7, 459-469. http://dx.doi.org/10.1016/j.coph.2007.08.003
[6] Andrews, J. (2012) British Society for Antimicrobial Chemotherapy (BSAC) Detection of Extended-Spectrum β-Lactamases (ESBLs) in E. coli and Klebsiella Species.
http://bsac.org.uk/wp-content/uploads/2012/02/Ecoliklebsiella.pdf
[7] Friedman, C., Callery, S., Jeanes, A., Piaskowski, P. and Scott, L. (2005) Best Infection Control Practices for Patients with Extended Spectrum Beta Lactamase Enterobacteriacae. International Infection Control Council.
[8] Pitout, J.D.D. and Laupland, K.B. (2008) Extended Spectrum β Lactamase Producing Enterobacteriaceae: An Emerging Public Health Concern. Lancet Infectious Diseases, 8, 159-166.
http://dx.doi.org/10.1016/S1473-3099(08)70041-0
[9] Shivaprakasha, S., Radhakrishnan, K., Gireesh, A.R. and Shamsul Karim, P.M. (2007) Routine Screening for ESBL Production. A Necessity of Today. Internet Journal of Microbiology, 3.
[10] Sasirekha, B., Manasa, R., Ramya, P. and Sneha, R. (2010) Frequency and Antimicrobial Sensitivity Pattern of Extended Spectrum β-Lactamases Producing Esch. coli and Klebsiella pneumoniae Isolated in a Tertiary Care Hospital. Al Ameen Journal of Medical Science, 3, 265-271.
[11] Shobha, K.L., Gowrish, R.S., Sugandhi, R. and Sreeja, C.K. (2007) Prevalence of Extended Spectrum β Lactamases in Urinary Isolates of Escherichia coli, Klebsiella and Citrobacter Species and Their Antimicrobial Susceptibility Pattern in Tertiary Care Hospital. Indian Journal for the Practising Doctor, 3, 1-2.
[12] Agrawal, P., Ghosh, A., Kumar, S., Basu, B. and Kapil, K. (2008) Prevalence of Extended Spectrum β Lactamases among E. coli and K. pneumoniae Isolates in Tertiary Care Hospital. Indian Journal of Pathology and Microbiology, 51, 139-142. http://dx.doi.org/10.4103/0377-4929.40428
[13] Yushau, M., Aliyu, H.M., Kumurya, A.S. and Suleiman, K. (2010) Prevalence of Extended Spectrum β Lactamases among Enterobacteriaceae in Murtala Mohammed Specialist Hospital, Kano, Nigeria. Bayero Journal of Pure and Applied Sciences, 3, 169-172.
[14] Hawkey, P.M. (2008) Prevalence and Clonality of Extended-Spectrum β-Lactamases in Asia. Clinical Microbiology and Infection, 14, 159-165. http://dx.doi.org/10.1111/j.1469-0691.2007.01855.x
[15] Rahman, M.M., Haque, J.A., Hossain, M.A., Sultana, R. and Islam, F. (2004) Prevalence of Extended Spectrum Beta Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in an Urban Hospital in Dhaka Bangladesh. International Journal of Antimicrobial Agents, 24, 508-510.
http://dx.doi.org/10.1016/j.ijantimicag.2004.05.007
[16] Cheessbrough, M. (2006) District Laboratory Practice in Tropical Countries. Microbiology-2, Cambridge University Press, New York, 184-186.
[17] Clinical Laboratory Standards Institute (2010) Performance Standards for Antimicrobial Disc Susceptibility Testing. 14th Informational Supplement.
[18] Clinical Laboratory Standards Institute (2006) Performance Standards for Antimicrobial Susceptibility Testing. 16th Informational Supplement, M100-S15.
[19] National Committee for Clinical Laboratory Standards (2003) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, M7-A6.
[20] Haque, N., Hossain, M.A., Bilkis, L., Musa, A.K., Mahamud, C., Bari, M.S., et al. (2009) Antibiotic Susceptibility Pattern of Staphylococcus epidermidis. Mymensingh Medical Journal, 18, 142-147.
[21] Haque, R. and Salam, M.A. (2010) Detection of ESBL Producing Nosocomial Gram Negative Bacteria from a Tertiary Care Hospital in Bangladesh. Pakistan Journal of Medical Sciences, 26, 887-891.
[22] Jabeen, K., Zafar, A., Hasan, R., et al. (2005) Frequency and Sensitivity Pattern of Extended Spectrum Beta Lactamase Producing Isolates in a Tertiary Care Hospital Laboratory of Pakistan. Journal of Pakistan Medical Association, 55, 436-439.
[23] Ullah, F., Malik, S.A. and Ahmed, J. (2009) Antimicrobial Susceptibility Pattern and ESBL Prevalence in Klebsiella pneumoniae from Urinary Tract Infections in the North-West of Pakistan. African Journal of Microbiology Research, 3, 670-680.
[24] Ali, A.M. (2009) Frequency of Extended Spectrum Beta Lactamase (ESBL) Producing Nosocomial Isolates in a Tertiary Care Hospital in Rawalpindi. Journal of the Royal Army Medical Corps, 3, 105-109.
[25] Babypadmini, S. and Appalaraju, B. (2004) Extended Spectrum Beta Lactamases in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae-Prevalence and Susceptibility Pattern in a Tertiary Care Hospital. Indian Journal of Medical Microbiology, 22, 172-174.
[26] Sharma, S., Bhat, G.K. and Shenoy, S. (2007) Virulence Factors and Drug Resistance in Escherichia coli Isolated from Extra Intestinal Infections. Indian Journal of Medical Microbiology, 25, 369-373. http://dx.doi.org/10.4103/0255-0857.37341
[27] Naehi, L., Shahcheraghi, F., Nikbin, V.S. and Nematzadeh, S. (2010) PER, CTX-M, TEM and SHV Beta Lactamases in Clinical Isolates of Klebsiella pneumoniae Isolated from Tehran, Iran. Iranian Journal of Basic Medical Sciences, 13, 111-118.
[28] Lal, P., Kapil, A., Das, B.K. and Sood, S. (2007) Occurrence of TEM and SHV Gene in Extended Spectrum Beta Lactamases (ESBLs) Producing Klebsiella spp. Isolated from a Tertiary Care Hospital. Indian Journal of Medical Research, 125, 173-178.
[29] Sharma, J., Sharma, M. and Roy, P. (2010) Detection of TEM and SHV Genes in Escherichia coli and Klebsiella pneumoniae Isolates in a Tertiary Care Hospital from India. Indian Journal of Medical Microbiology, 132, 332-336.
[30] Tenover, F.C., Mohammed, M.J., Gorton, T.S. and Dembek, Z.F. (1999) Detection and Reporting of Organisms Producing Extended Spectrum Beta-Lactamases: Survey of Laboratories in Connecticut. Journal of Clinical Microbiology, 37, 4065-4070.
[31] Paterson, D.L. and Yu, V.L. (1999) Extended Spectrum Beta Lactamases: A Call for Improved Detection and Control. Clinical Infectious Diseases, 29, 1419-1422. http://dx.doi.org/10.1086/313559
[32] Asna, S.M.Z. and Haq, J.A. (2000) Decrease of Antibiotic Resistance in Salmonella typhi Isolated from Patients Attending Hospitals of Dhaka City over a 3 Year Period. International Journal of Antimicrobial Agents, 16, 249-251. http://dx.doi.org/10.1016/S0924-8579(00)00230-2
[33] Paterson, D.L., Ko, W.C., Gottberg, V., Mohapatra, S., Casellas, J.M., Goossens, H., et al. (2004) Antibiotic Therapy for Klebsiella pneumoniae Bacteriamia: Implications of Production of Extended-Spectrum β-Lactamases. Antibiotics for ESBL Producers CID, 39, 31-37.
[34] Singh, N.P. and Goyal, R. (2003) Changing Trends in Bacteriology of Burns in the Burns Unit, Delhi, India. Burns, 29, 129-132. http://dx.doi.org/10.1016/S0305-4179(02)00249-8
[35] Gonzalez, L.S. and Spencer, J.P. (1998) Aminoglycosides: A Practical Review. American Family Physician, 58, 1811-1820.
[36] Miller, G.H. and Sabatelli, F.J. (1997) The Most Frequent Aminoglycoside Resistance Mechanisms—Changes with Time and Geographic Area: Areflection of Aminoglycoside Usage Patterns? Aminoglycoside Resistance Study Groups. Clinical Infectious Diseases, 24, 46-62.
http://dx.doi.org/10.1093/clinids/24.Supplement_1.S46
[37] Rashid, A., Chowdhury, A., Rahman, S.H., Begum, S.A. and Muazzam, N. (2007) Infections by Pseudomonas aeruginosa and Antibiotic Resistance Pattern of the Isolates from Dhaka Medical College Hospital. Bangladesh Journal of Medical Microbiology, 1, 48-51.
[38] Rhee, Y.J., Park, Y.K., Lee, M.Y., Peck, K.R. and Soo, K.K. (2010) KPC-Producing Extreme Drug-Resistant Klebsiella pneumoniae Isolated from a Patient with Diabetes Mallitus and Chronic Renal Failure on Haemodialysis in South Korea. Antimicrobial Agents and Chemotherapy, 54, 2278-2279.
http://dx.doi.org/10.1128/AAC.00011-10
[39] Amaya, E., Caceres, M., Fang, H., Ramirez, A.T., Palmgren, A.C., Nord, C.E. and Weintraub, A. (2009) Extended Spectrum Beta Lactamase-Producing Klebsiella pneumoniae in a Neonatal Intensive Care Unit in Leon, Nicaragua. International Journal of Antimicrobial Agents, 33, 386-387.
http://dx.doi.org/10.1016/j.ijantimicag.2008.10.004